| Patient characteristics | N = 756 |
| Age at start of first-line therapy (years) |
|
| Mean (SD) | 60.8 (12.6) |
| Median | 61.2 |
| Range (minimum - maximum) | 26.2 - 93.3 |
| Age at start of first-line therapy, n (%) |
|
≥18 - <50 years | 156 (20.6) |
| ≥50 - <65 years | 304 (40.2) |
| ≥65 years | 296 (39.2) |
| Gender, n (%) |
|
| Male | 418 (55.3) |
| Female | 338 (44.7) |
| Diagnosis, n (%) |
|
| Colon | 583 (77.1) |
| Rectal | 172 (22.8) |
| Both | 1 (0.1) |
| Body Mass Index, n (%) |
|
| Normal | 328 (43.4) |
| Overweight | 255 (33.7) |
| Obese | 173 (22.9) |
| ECOG at index date 1, n (%) of 756 1L patients |
|
| 0 | 161 (21.3) |
| 1 | 488 (64.6) |
| ≥2 | 85 (11.2) |
| Unknown | 22 (2.9) |
| ECOG at index date 2, n (%) of 743 2L patients |
|
| 0 | 112 (15.1) |
| 1 | 510 (68.6) |
| ≥2 | 99 (13.3) |
| Unknown | 22 (2.9) |
| ECOG at index date 3, n (%) of 577 3L patients |
|
| 0 | 58 (10.1) |
| 1 | 396 (68.6) |
| ≥2 | 106 (18.4) |
| Unknown | 17 (3.0) |
| Metastasis location at start of first-line therapy, n (%) |
|
| Liver only | 214 (28.3) |
| Lung only | 24 (3.2) |
| Bone, ovary, peritoneum, or retroperitoneum only | 20 (2.6) |